Appropriateness of Coronary Artery Bypass Graft Surgery Performed in Northern New England

Size: px
Start display at page:

Download "Appropriateness of Coronary Artery Bypass Graft Surgery Performed in Northern New England"

Transcription

1 Journal of the American College of Cardiology Vol. 51, No. 24, by the American College of Cardiology Foundation ISSN /08/$34.00 Published by Elsevier Inc. doi: /j.jacc Coronary Artery Surgery Appropriateness of Coronary Artery Bypass Graft Surgery Performed in Northern New England Gerald T. O Connor, PHD, SCD,* Elaine M. Olmstead, BA, William C. Nugent, MD, Bruce J. Leavitt, MD, Robert A. Clough, MD, Paul W. Weldner, MD,# David C. Charlesworth, MD, Kristine Chaisson, RN, BSN, MS, Donato Sisto, MD, Edward R. Nowicki, MD, MS,** Richard P. Cochran, MD, David J. Malenka, MD, for the Northern New England Cardiovascular Disease Study Group Bangor, Lewiston, and Portland, Maine; Concord, Hanover, Lebanon, Manchester, and Portsmouth, New Hampshire; Cleveland, Ohio; and Burlington, Vermont Objectives Background The goal of this study was to assess the concordance between the American College of Cardiology (ACC) and the American Heart Association (AHA) 2004 Guideline Update for Coronary Artery Bypass Graft Surgery and actual clinical practice. There is substantial geographic variability in the population-based rates of coronary artery bypass graft (CABG) procedures, and in recent years, there have been several public concerns about unnecessary cardiac care. The actual rate of inappropriate cardiac procedures is unknown. Methods We evaluated 4,684 consecutive isolated coronary artery bypass graft procedures performed in 2004 and 2005 in northern New England. Our regional registry data were used to categorize patients into clinical subgroups. Detailed clinical criteria were then used to categorize procedures within these subgroups as class I (useful and effective), class IIa (evidence favors usefulness), class IIb (evidence less well established), and class III (not useful or effective). Results Conclusions Among these 4,684 procedures, we were able to classify 99.6% (n 4,665). The majority of procedures were class I (87.7%). Class II procedures totaled 10.9%. The remaining 1.4% of procedures were class III. In this regional study, we found that 98.6% of CABG procedures that could be classified were considered to be appropriate. In these data, actual clinical practice closely follows the recommendations of the 2004 ACC/AHA guidelines for CABG surgery. (J Am Coll Cardiol 2008;51:2323 8) 2008 by the American College of Cardiology Foundation Since it was first described by Favaloro (1) and Garrett et al. (2), coronary artery bypass graft (CABG) surgery has become one of the most commonly performed and closely From the *Department of Medicine and of Community and Family Medicine, and the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire; Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire; Departments of Surgery and Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Department of Surgery, Fletcher Allen Health Care, Burlington, Vermont; Department of Surgery, Eastern Maine Medical Center, Bangor, Maine; #Department of Surgery, Maine Medical Center, Portland, Maine; **Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio; Department of Surgery, Catholic Medical Center, Manchester, New Hampshire; Department of Surgery, Concord Hospital, Concord, New Hampshire; Department of Surgery, Portsmouth Regional Medical Center, Portsmouth, New Hampshire; and the Department of Cardiothoracic Surgery, Central Maine Medical Center, Lewiston, Maine. Funded by the Northern New England Cardiovascular Disease Study Group, Lebanon, New Hampshire. Manuscript received November 2, 2007; revised manuscript received January 11, 2008, accepted January 21, examined major surgical procedure. In 2003, it was estimated that there were 348,218 CABG procedures performed in the U.S. (3). Among Medicare enrollees, there is more than 5-fold variability in the population-based rates of CABG procedures and this has raised concerns about the inappropriate use of this procedure (4). In recent years, there have been several public accusations of unnecessary cardiac care (5 7). These have originated from a variety of sources including patient complaints, insurance company concerns, and medical staff actions. The actual rate of inappropriate cardiac surgery is unknown, but it can be assessed by a detailed comparison of actual clinical practice to the professional guidelines. Evidence-based guidelines for CABG surgery have been available for many years. In 1972, Wright and Frederickson (8) edited a report on the minimum resources required to perform cardiac surgery safely. In 1980, the American

2 2324 O Connor et al. JACC Vol. 51, No. 24, 2008 Appropriateness of CABG Surgery June 17, 2008: Abbreviations and Acronyms ACC American College of Cardiology AHA American Heart Association CABG coronary artery bypass graft PTCA percutaneous transluminal coronary angioplasty College of Cardiology (ACC) and the American Heart Association (AHA) established the Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. In 1991, Kirklin chaired a joint committee to develop guidelines and indications for CABG surgical procedure (9). These guidelines were substantially updated in 1999 by a committee cochaired by Eagle and Guyton (10) and were updated again in 2004 (11). The application of the ACC/AHA guidelines to current clinical care has not been assessed. The Northern New England Cardiovascular Disease Study Group (NNECDSG) is a voluntary research consortium composed of clinicians, scientists, and hospital administrators. The intent of the group is to foster continuous improvement in the quality of cardiovascular disease care through the sharing of process and outcome data. The NNECDSG includes all 8 cardiac surgery programs in Maine, New Hampshire, and Vermont. Each center contributes data on every case. These data provide an opportunity to assess the concordance between the guidelines and actual clinical care. Methods Data collection. This database includes 4,684 consecutive cases of isolated CABG procedures performed in 2004 and All data were validated using the Uniform Hospital Discharge Data Set, and any discordance was settled by review of the medical records. The capture rate of procedures through 2004 and 2005 was assessed by comparing forms submitted to the CABG registry against administrative discharge records supplied by the participating medical centers. The capture rate was initially 96.9%. Missing records were obtained from each center to ensure 100% capture. This analysis of concordance between the ACC/ AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery (11) and the actual care provided included only patients undergoing CABG surgical procedure. We do not collect data on patients who are eligible for a CABG procedure but did not receive it. Coding of clinical subgroups. Registry data elements were used to assign patients to a clinical subgroup as described in the ACC/AHA guidelines for CABG surgery (summarized in Fig. 1). The row labels identify the clinical subgroups. These include CABG after failed percutaneous transluminal coronary angioplasty (PTCA), ST-segment elevation myocardial infarction, patients with previous CABG, patients with poor left ventricular function, unstable angina/non ST-segment elevation myocardial infarction, asymptomatic or mild angina, and stable angina. Because the NNECDS group CABG registry does not collect information regarding life-threatening ventricular arrhythmias, it was not possible to include that clinical subgroup in these analyses. In our experience, this is a rare indication for CABG surgery. In a study of indications for CABG procedures performed in New York, life-threatening ventricular arrhythmia was the indication in less than 1% of cases (12). The column entries describe the criteria for the appropriateness classes. All 4,684 patients were assigned to a clinical subgroup. The clinical subgroups as described in the guidelines are not mutually exclusive. It was possible for patients to fall into more than 1 group. For example, prior CABG procedure or failed PTCA may coexist with any of the other clinical subgroups. In order to calculate the appropriateness classes, it was necessary to assign patients to a single clinical subgroup. In this analysis, 71.0% of patients were coded into 1 group, 23.6% into 2 groups, 4.7% into 3 groups, and 0.7% into 4 groups. If a patient was included in more than 1 subgroup, we assigned that patient to the clinical subgroup with the highest mortality risk. The observed in-hospital mortality rates following CABG procedure were as follows: stable angina (1.0%), asymptomatic or mild angina (1.7%), unstable angina/non ST-segment elevation myocardial infarction (2.4%), poor left ventricular function (3.8%), with previous CABG (4.2%), ST-segment elevation myocardial infarction (6.7%), and failed PTCA (10.7%). Within each clinical subgroup, patients were placed into class I (useful and effective), IIa (evidence favors the procedure), IIb (evidence less well established), or III (not useful and may be harmful) by following the specific text of the guidelines as closely as possible. Coding of appropriateness classes. The criteria for coding appropriateness are summarized in Figure 1. Most patients were classified easily based on readily available clinical data on coronary anatomy, left ventricular function, and the presence of angina. Some patients were more difficult to classify. For example, the guidelines consider patients in the poor left ventricular function group as class III if they are without evidence of intermittent ischemia and without evidence of significant revascularizable viable myocardium. In this study, patients in the poor left ventricular function group were coded as class III by registry data if they did not have: 1) left main disease; 2) proximal left anterior descending artery and circumflex disease; or 3) proximal left anterior descending artery with 2- or 3-vessel disease and who also lacked objective evidence of ischemia. Evidence of ischemia was defined by the results of exercise treadmill testing, nuclear imaging, stress echocardiography, or the presence of unstable angina treated with intravenous nitroglycerin. The issue of whether or not the myocardium was revascularizable cannot be assessed easily in the clinical setting or in these data. Individual surgeons must decide whether or not the target lesion can be bypassed. The class III indications for the stable angina group include: 1. One- or 2-vessel disease not involving

3 JACC Vol. 51, No. 24, 2008 June 17, 2008: O Connor et al. Appropriateness of CABG Surgery 2325 Figure ACC/AHA Indications for Isolated CABG Surgery Classification Tool Directions for using the tool: 1) Place patient in highest clinical subgroup that describes the indication. 2) Within the selected subgroup, evaluate patient for class I, IIa, IIb, or III. ACC American College of Cardiology; AHA American Heart Association; CABG coronary artery bypass graft; EF ejection fraction; LAD left anterior descending; LBBB left bundle branch block; LM left main; LV left ventricular; MI myocardial infarction; PCI percutaneous coronary intervention; Prox. proximal; PTCA percutaneous transluminal coronary angioplasty; STEMI ST-segment elevation myocardial infarction; 1VD 1-vessel disease; 2VD 2-vessel disease; 3VD 3-vessel disease. Data from Eagle et al. (11). significant proximal LAD stenosis, patients who have mild symptoms that are unlikely to be due to myocardial ischemia or patients who have not received an adequate trial of medical therapy and (a) have only a small area of viable myocardium or (b) have no demonstrable ischemia on noninvasive testing; 2. Borderline coronary stenoses (50% to 60% diameter in locations other than the left main coronary artery) and no demonstrable ischemia on noninvasive testing; 3. Insignificant coronary stenosis ( 50% diameter reduction) (11). When data for key elements of the guidelines were missing, we made no assumptions about the missing data and those patients remained unclassified unless they were coded into a class by other criteria. No patient was placed in class III because of missing data. Statistical methods. Standard statistical methods were used for the calculation of rates and proportions and the chi-square test (13). A nonparametric test of trend across ordered groups was used to identify any significant trend in proportion of class III patients across age groups (14). Statistical significance was defined as a 2-tailed p value All analyses were performed using the STATA statistical program (Version 6.0, StataCorp, College Station, Texas). Results Appropriateness of CABG procedure. Of the 4,684 patients, we were able to classify 99.6%; 19 (0.4%) could not be unambiguously classified. Largely, these patients could not be placed into appropriateness classes because of missing data on the details of coronary anatomy or on left ventricular ejection fraction. The remaining 4,665 patients were grouped into appropriateness classes: 87.7% were class I, 10.9% were class II (class IIa 8.4% and class IIb 2.5%), and 1.4% were class III (Fig. 2, Table 1). Thus, of the 4,665 CABG procedures, 4,598 (98.6%) were classified as appropriate according to the ACC/AHA guidelines for CABG surgery. Table 1 and Figure 3 describe the appropriateness of CABG surgical procedure by clinical subgroup. Among 56 patients in the clinical subgroup CABG procedure follow-

4 2326 O Connor et al. JACC Vol. 51, No. 24, 2008 Appropriateness of CABG Surgery June 17, 2008: Percent Figure I IIa IIb III Class ACC/AHA Indications for CABG Patients were classified using the 2004 ACC/AHA guidelines. Abbreviations as in Figure 1. ing a failed PTCA, 98.2% were class I and 1.8% were class III. Class II indications for CABG following a failed PTCA are for infrequent clinical situations, that is, a foreign body in a crucial anatomic position or hemodynamic compromise with significant impairment of the coagulation system. Among the 233 patients in the ST-segment elevation myocardial infarction subgroup, 99.6% were class I, 0.4% class IIA, and none in class III (there are no described criteria for class IIb). There were 166 patients in the clinical subgroup defined by previous CABG procedure. Among these, 85.5% were class I, 11.5% were class IIa (no class IIb criteria), and 3.0% were class III. Poor left ventricular function was a frequent clinical subgroup for CABG procedure. Among these 874 patients, 71.2% were class I, 23.8% were class IIa, and 5.0% were class III. There is no class IIb indication within this clinical subgroup. Unstable angina/non ST-segment elevation myocardial infarction was the most frequent clinical subgroup for CABG procedure. Of these 2,294 patients, 93.9% were class I and 6.1% were class II (class IIa 3.0% and class IIb 3.1%). There were no class III patients. There were 236 patients with asymptomatic or mild angina as the clinical subgroup for CABG procedure. Among these patients, 77.5% were class I, 22.4% were class II (class IIa 2.5% and class IIb 19.9%), and there were no class III patients. Stable angina was a relatively frequent clinical subgroup for CABG procedure. Of these 806 patients, 87.1% were class I, 10.8% were class IIa, and 2.1% were class III. There is no class IIb category for this clinical subgroup. Appropriateness by patient sex and age. The distribution of appropriateness classes for men and women are virtually identical (class I men 87.5%, women 88.2%; class II men 11.2%, women 10.0%; class III men 1.3%, women 1.9%). There was no statistical difference in the distributions (chi-square test with 2 degrees of freedome 3.32, p 0.190). The appropriateness classes by patient age at surgery showed no significant association between age and class III rates (p trend 0.865). There was a trend, however, toward more class I and fewer class II indicators with increasing age (p trend 0.001). Clinical subgroup analysis of class III patients. Of 4,684 patients, 67 were class III. Figure 4 shows the distribution of these patients by clinical subgroups. Patients with poor left ventricular function (65.7% of class III) or stable angina (25.4% of class III) totaled 91% of class III patients. The remaining 9% had either a previous CABG procedure (7.5%) or CABG after a failed PTCA (1.5%). Discussion We assessed the concordance between the 2004 ACC/ AHA Guideline Update for Coronary Artery Bypass Graft Surgery (11) and actual clinical practice in northern New England. Detailed clinical criteria were used to categorize 4,684 isolated CABG procedures performed in 2004 and The majority of procedures were class I (87.7%). Class II procedures totaled 10.9%, 8.4% were class IIa and 2.5% were class IIb. The remaining 1.4% were class III procedures. Only 19 procedures could not be classified. In these regional data, actual clinical practice closely followed the recommendations of the 2004 ACC/AHA guidelines for CABG surgery (11). There were some limitations to these analyses and likely some misclassification of patients. The concordance between our regional registry data and the variables required by the ACC/AHA guidelines for CABG surgery was good, but it was not perfect. We were able to classify 99.6% of patients to both a clinical subgroup and to an appropriateness class. The primary reason for being unable to classify a patient was missing data on details of ACC/AHA Indications by Clinical Subgroup Table 1 Clinical Subgroup n* CABG after failed PTCA ST-segment elevation MI Patients with previous CABG procedure Patients with poor LV function Unstable angina/ non STsegment elevation MI Asymptomatic or mild angina ACC/AHA Indications by Clinical Subgroup Class I Class IIa Indication Class IIb Class III , Stable angina All 4, *Patients who could not be classified (n 19) are excluded from this table. There are no indications for this class within this clinical subgroup. ACC American College of Cardiology; AHA American Heart Association; CABG coronary artery bypass graft; LV left ventricular; MI myocardial infarction; PTCA percutaneous transluminal coronary angioplasty.

5 JACC Vol. 51, No. 24, 2008 June 17, 2008: O Connor et al. Appropriateness of CABG Surgery 2327 Percent Failed PTCA STEMI Previous CABG Poor LV func. UA/NSTEMI Asymp/mild angina Stable angina Class I Class IIa Class IIb Class III Figure 3 ACC/AHA Indications by Clinical Subgroup Patients were classified using the 2004 ACC/AHA guidelines. Asymp asymptomatic; LV func. left ventricular function; NSTEMI non ST-segment elevation myocardial infarction; UA unstable angina; other abbreviations as in Figure 1. coronary anatomy or measurement of left ventricular function. Some variables included in the ACC/AHA guidelines for CABG surgery, such as quantity of viable myocardium and impairment of the coagulation system, are difficult to interpret and further clarification from the committee would be helpful. Overall, we felt that the ACC/AHA guidelines for CABG surgery included variables that were clinically relevant and the application of the guidelines was straightforward. There have been several other studies of the appropriateness of CABG surgical procedure. In the mid-1980s, investigators associated with the RAND Corporation and the University of California at Los Angeles developed Delphi panel-based CABG guidelines (12). These guidelines were applied in New York (15), at 3 hospitals in an unidentified western state (12), at academic medical centers Stable angina 25.4% Figure 4 Failed PTCA 1.5% Previous CABG 7.5% Proportion of Class III Patients by Clinical Subgroup (N 67) Chart shows the proportion of class III patients in each subgroup. Abbreviations as in Figure 1. Poor LV function 65.7% (16), and were used to compare cardiovascular care in Canada and New York (17). The RAND investigators found that inappropriate CABG surgery varied from 1.6% at academic medical centers to 14% in the 3 hospitals in 1 western state. Leape et al. (18) randomly selected a group of 676 patients who had CABG procedures in 1991 or Their medical records were reviewed by the staff of the professional review organizations and a computerized algorithm was used to code the appropriateness class based on the ACC/AHA 1991 Guidelines for Coronary Artery Bypass Graft Surgery (9). They assessed 1.5% of patients to be class III. This study showed no obvious or statistically significant difference in the appropriateness of cardiac surgery of men and women. Ayanian and Epstein (19) used 1987 data abstracted from 49,623 patients discharged from Massachusetts hospitals and 33,159 patients discharged from Maryland hospitals to study the rates of coronary angiography and CABG procedures. After adjusting for important patient and disease characteristics, they found that women received significantly less coronary angiography than men. These data did not allow them to study the appropriateness of angiography or CABG procedures. Bernstein et al. (20) used retrospective chart review to study the use of cardiovascular procedures among 3,979 patients receiving care during 1990 in 30 New York hospitals. They used the RAND appropriateness score to evaluate the appropriateness of coronary angiography, PTCA, and CABG procedures and compared men and women. The rate of CABG procedures judged to be inappropriate was 2% among men and 3% among women. The current study is in agreement with that of Bernstein et al. (20). If there is a gender-related difference it must occur before the decision to perform cardiac surgery. Our study of class III patients suggests opportunities for improving clinical decision making. Sixty-six percent of the

6 2328 O Connor et al. JACC Vol. 51, No. 24, 2008 Appropriateness of CABG Surgery June 17, 2008: class III patients had poor left ventricular function. Coronary artery surgery in these patients should be conditional on establishing the ischemic origin of the cardiomyopathy and the presence of sufficient viable myocardium for successful revascularization to improve pump function. Thallium-201 rest redistribution imaging, positron emission tomography, and dobutamine stress echocardiography have all been shown to be good tests for assessing regional myocardial viability (21). Information from these studies should be available when making decisions for patients with depressed ejection fractions. Another group of class III patients were those with stable angina. For these patients, the clinical issue, beyond establishing their coronary anatomy, is proving that the symptoms are due to ischemia from flow-limiting coronary lesions and that these symptoms are not adequately controlled with a reasonable medical regimen. These patients require stress testing to establish the ischemic origin of their pain. When coronary lesions of questionable significance are identified at catheterization, some physiologic assessment of their significance, with a pressure or Doppler wire, would be helpful. In this study, we used data from consecutive cases from a validated regional registry to assess the appropriateness of CABG procedures based on the 2004 guidelines for CABG surgery (11). This was informative and demonstrated that clinical care closely followed the current ACC/AHA guidelines for CABG surgery. These analyses also identified subgroups of patients (those with poor left ventricular or with stable angina) that are more likely to be class III. This could lead to improved decision making for these patients. However, the real utility of the treatment guidelines lies in their prospective use. We have summarized the appropriateness section of the AHA/ACC 2004 Guideline Update for Coronary Artery Bypass Graft Surgery (Fig. 1). With this tool, it takes only a few minutes to place a patient into a clinical subgroup and to assign an appropriateness class. Evidence-based medicine mandates the constant examination of the appropriateness of invasive procedures. Physicians can and should lead this effort. No one else is as well suited to be a patient s advocate. The ACC/AHA guidelines for CABG surgery can play an important role in this task. The guidelines provide a synthesis of the current evidence of the effectiveness and appropriateness of this procedure. The prospective use of the guidelines provides for documentation of appropriateness of care in the medical record and discussion of the evidence with the patient. In our view, the routine use of the guidelines benefits the patient, the physician, and the hospital. Reprint requests and correspondence: Dr. Gerald T. O Connor, Clinical Research, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Rubin Building, Room 510, Lebanon, New Hampshire gerald.t.oconnor@dartmouth.edu. REFERENCES 1. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg 1968;5: Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous vein graft. Seven-year follow-up. JAMA 1973;223: Merrill C, Elixhauser A. Procedures in U.S. Hospitals, AHRQ Publication No ed. Rockville, MD: Agency for Healthcare Research and Quality, The Center for the Evaluative Clinical Sciences DMS, The Center for Outcomes Research and Evaluation MMC. Dartmouth Atlas of Cardiovascular Health Care. Chicago, IL: AHA Press, Pollack A. California Patients Talk of Needless Heart Surgery. New York Times. November 3, 2002;sect C:1. 6. Holland J, Carlson K. Insurer blasts DMC surgery Blue Shield review says 13 of 23 heart bypass operations unnecessary. Modesto Bee. November 4, 2003:A1. 7. Quality assurance: Interventional cardiac privileges of eight physicians suspended. Managed Care Weekly Digest. February 24, 2003: Wright IS, Frederickson DT. Cardiovascular Diseases: Guidelines for Prevention and Care: Reports of the Inter-Society Commission for Heart Disease Resources. Washington, DC: Government Printing Office, Kirklin JW, Akins CW, Blackstone EH, et al. Guidelines and indications for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1991;17: Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1999;34: Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 2004;44: Winslow CM, Kosecoff JB, Chassin M, Kanouse DE, Brook RH. The appropriateness of performing coronary artery bypass surgery. JAMA 1988;260: Armitage P, Berry G. Statistical Methods in Medical Research. 2nd edition. London: Blackwell Scientific Publications, Cuzick J. A Wilcoxon-type test for trend [see comments]. Stat Med 1985;4: Leape LL, Hilborne LH, Park RE, et al. The appropriateness of use of coronary artery bypass graft surgery in New York State. JAMA 1993;269: Leape LL, Hilborne LH, Schwartz JS, et al., on behalf of the Working Group of the Appropriateness Project of the Academic Medical Center Consortium. The appropriateness of coronary artery bypass graft surgery in academic medical centers. Ann Intern Med 1996;125: McGlynn EA, Naylor CD, Anderson GM, et al. Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. JAMA 1994;272: Leape LL, Weissman JS, Schneider EC, Piana RN, Gatsonis C, Epstein AM. Adherence to practice guidelines: the role of specialty society guidelines. Am Heart J 2003;145: Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325: Bernstein SJ, Hilborne LH, Leape LL, Park RE, Brook RH. The appropriateness of use of cardiovascular procedures in women and men. Arch Intern Med 1994;154: Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital Complex PCI: Multivessel Disease George W. Vetrovec, MD. Kimmerling Chair of Cardiology VCU Pauley Heart Center Virginia

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

Interventional Cardiology

Interventional Cardiology Interventional Cardiology Adherence of Catheterization Laboratory Cardiologists to American College of Cardiology/American Heart Association Guidelines for Percutaneous Coronary Interventions and Coronary

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England

Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING. Mouin S.

CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING. Mouin S. CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING BY Mouin S. Abdallah Submitted to the graduate degree program in Clinical research

More information

COURAGE to Leave Diseased Arteries Alone

COURAGE to Leave Diseased Arteries Alone COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist

More information

The American College of Cardiology/American Heart

The American College of Cardiology/American Heart ACC/AHA/SCAI Practice Guideline ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention Summary Article A Report of the American College of Cardiology/American Heart Association Task

More information

I have no financial disclosures

I have no financial disclosures Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic

More information

Guideline Number: NIA_CG_024 Last Review Date: January 2011 Responsible Department: Last Revised Date: May 2, 2011 Clinical Operations

Guideline Number: NIA_CG_024 Last Review Date: January 2011 Responsible Department: Last Revised Date: May 2, 2011 Clinical Operations National Imaging Associates, Inc. Clinical guidelines NUCLEAR CARDIAC IMAGING (MYOCARDIAL PERFUSION STUDY) CPT Codes: 78451, 78452, 78453, 78454, 78466, 78468, 78469, 78481, 78483, 78494, 78499 Original

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Corrective Surgery in Severe Heart Failure Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Session Objectives 1.) Identify which patients with severe

More information

Coronary interventions

Coronary interventions Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood Revascularization In HFrEF: Are We Close To The Truth Ali Almasood HF epidemic 1-2% of the population have HF At least one-half have heart failure with reduced ejection fraction (HF- REF) The most common

More information

2017 Cardiology Survival Guide

2017 Cardiology Survival Guide 2017 Cardiology Survival Guide Chapter 4: Cardiac Catheterization/Percutaneous Coronary Intervention A cardiac catheterization involves a physician inserting a thin plastic tube (catheter) into an artery

More information

FFR in Multivessel Disease

FFR in Multivessel Disease FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

Rational use of imaging for viability evaluation

Rational use of imaging for viability evaluation EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium

More information

Coronary Artery Disease: Revascularization (Teacher s Guide)

Coronary Artery Disease: Revascularization (Teacher s Guide) Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention

More information

A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty

A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty JACC Vol. 33, No. 1 January 1999:63 72 63 INTERVENTIONAL CARDIOLOGY A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty EDWARD

More information

Viability Testing Using Dynamic Echocardiography

Viability Testing Using Dynamic Echocardiography Viability Testing Using Dynamic Echocardiography Theodora A Zaglavara, MD, PhD Director of Echocardiography EUROMEDICA KYANOUS STAVROS HOSPITAL Thessaloniki GREECE Goals of Cardiac Imaging in Coronary

More information

Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality

Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality ADULT CARDIAC J. MAXWELL CHAMBERLAIN MEMORIAL PAPER Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality Elizabeth L. Nichols, MS, Jock N. McCullough, MD,

More information

Cardiopulmonary Bypass Recommendations in Adults: The Northern New England Experience

Cardiopulmonary Bypass Recommendations in Adults: The Northern New England Experience The Journal of The American Society of Extra-Corporeal Technology Cardiopulmonary Bypass Recommendations in Adults: The Northern New England Experience Christian P. DioDato, CCP;* Donald S. Likosky, PhD;

More information

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology Stable Ischemic Heart Disease Ivan Anderson, MD RIHVH Cardiology Outline Review of the vascular biology of atherosclerosis Why not just cath everyone with angina? Medical management of ischemic cardiomyopathy

More information

Outpatient Cardiac Rehabilitation

Outpatient Cardiac Rehabilitation Last Review Date: May 12, 2017 Number: MG.MM.ME.26bC3v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

My Patient Needs a Stress Test

My Patient Needs a Stress Test My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update Journal of the American College of Cardiology Vol. 59, No. 9, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.001

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

FFR Incorporating & Expanding it s use in Clinical Practice

FFR Incorporating & Expanding it s use in Clinical Practice FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL

More information

Coronary atherosclerotic heart disease remains the number

Coronary atherosclerotic heart disease remains the number Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,

More information

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

The Influence of Race on Health Status Outcomes One Year After an Acute Coronary Syndrome

The Influence of Race on Health Status Outcomes One Year After an Acute Coronary Syndrome Journal of the American College of Cardiology Vol. 46, No. 10, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.092

More information

Patient-Centered Primary Care Scorecard Measures

Patient-Centered Primary Care Scorecard Measures Patient-Centered Primary Care Scorecard Measures Acute and Chronic Care Management Measures Medication Adherence Proportion of Days Covered (PDC): Oral Diabetes Identifies patients with at least two prescriptions

More information

CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION

CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION JAMES L ZELLNER MD I have no financial disclosures. 1897

More information

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS

More information

TSDA ACGME Milestones

TSDA ACGME Milestones TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short

More information

Fractional Flow Reserve and the Results of the FAME Study

Fractional Flow Reserve and the Results of the FAME Study Imaging and Physiology Summit Seoul, Korea November 21 st, 2009 Fractional Flow Reserve and the Results of the FAME Study William F. Fearon, M.D. Assistant Professor Division of Cardiovascular Medicine

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

Typical chest pain with normal ECG

Typical chest pain with normal ECG Typical chest pain with normal ECG F. Mut, C. Bentancourt, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history Male 41 y.o. Overweight, hypertension, high cholesterol,

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Percutanous revascularization of chronic total occlusion of diabetic patients at Iraqi center for heart diseases, a single center experience 2012

Percutanous revascularization of chronic total occlusion of diabetic patients at Iraqi center for heart diseases, a single center experience 2012 www.muthjm.com Muthanna Medical Journal 2015; 2(2):76-82 Percutanous revascularization of chronic total occlusion of diabetic patients at Iraqi center for heart diseases, a single center experience 2012

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Zachary I. Hodes, M.D., Ph.D., F.A.C.C.

Zachary I. Hodes, M.D., Ph.D., F.A.C.C. Zachary I. Hodes, M.D., Ph.D., F.A.C.C. Disclamer: I personally have no financial relationship with any company mentioned today. The Care Group, LLC does have a contract with Cardium to participate in

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan

More information

Management of Stable Coronary Disease

Management of Stable Coronary Disease T h e n e w e ng l a nd j o u r na l o f m e dic i n e C l i n i c a l D e c i s i o n s Interactive at www.nejm.org Management of Stable Coronary Disease This interactive feature addresses the diagnosis

More information

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

More information

Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI

Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI Center for Interventional Vascular Therapy Columbia University Medical Center / New York Presbyterian

More information

Guideline Number: NIA_CG_024 Last Revised Date: August 2011 Responsible Department: Implementation Date: January 2014 Clinical Operations

Guideline Number: NIA_CG_024 Last Revised Date: August 2011 Responsible Department: Implementation Date: January 2014 Clinical Operations National Imaging Associates, Inc. Clinical guidelines MYOCARDIAL PERFUSION IMAGING (aka NUCLEAR CARDIAC IMAGING STUDY) CPT Code: 78451, 78452, 78453, 78454, 78466, 78468, 78469, 78481, 78483, 78499 Original

More information

Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention

Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention Appropriate Use Criteria Effective Date: January 2, 2018 Proprietary Date of Origin: 08/27/2015 Last revised: 08/01/2017 Last reviewed:

More information

Preoperative White Blood Cell Count and Mortality and Morbidity After Coronary Artery Bypass Grafting

Preoperative White Blood Cell Count and Mortality and Morbidity After Coronary Artery Bypass Grafting Preoperative White Blood Cell Count and Mortality and Morbidity After Coronary Artery Bypass Grafting Lawrence J. Dacey, MD, Joseph DeSimone, MD, John H. Braxton, MD, Bruce J. Leavitt, MD, Stephen J. Lahey,

More information

Guideline Number: NIA_CG_024 Last Revised Date: August 2011 Responsible Department: Clinical. Implementation Date: January 2014 Operations

Guideline Number: NIA_CG_024 Last Revised Date: August 2011 Responsible Department: Clinical. Implementation Date: January 2014 Operations National Imaging Associates, Inc. Clinical guidelines NUCLEAR CARDIAC IMAGING MYOCARDIAL PERFUSION STUDY CPT Code: 78451, 78452, 78453, 78454, 78466, 78468, 78469, 78481, 78483, 78499 Original Date: October

More information

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London SYNTAX III REVOLUTION Trial Press briefing conference Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London Title: Coronary Computed Tomography Angiography for Heart Team Decision-making

More information

Debate Should we use FFR? I will say NO.

Debate Should we use FFR? I will say NO. Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea

More information

Invited Experts' Case Presentation and 5-Slides Focus Review

Invited Experts' Case Presentation and 5-Slides Focus Review Invited Experts' Case Presentation and 5-Slides Focus Review FFR and IVUS in Myocardial Bridging Haegeun, Song. M.D. Heart Institute, Asan Medical Center, Seoul, Korea Myocardial Bridging Common congenital

More information

Journal of the American College of Cardiology Vol. 51, No. 13, by the American College of Cardiology Foundation ISSN /08/$34.

Journal of the American College of Cardiology Vol. 51, No. 13, by the American College of Cardiology Foundation ISSN /08/$34. Journal of the American College of Cardiology Vol. 51, No. 13, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.10.064

More information

Medical Rx vs PCI vs CABG

Medical Rx vs PCI vs CABG Medical Rx vs PCI vs CABG S. Hinan Ahmed, MD Associate Professor: Cardiology and Cardiothoracic Surgery Program Director: Interventional Fellowship Program Assoc Editor: Cath and Cardiovasc Intervention

More information

Setting The setting was a hospital. The economic study was carried out in Australia.

Setting The setting was a hospital. The economic study was carried out in Australia. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,

More information

Adults With Diagnosed Diabetes

Adults With Diagnosed Diabetes Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et

More information

Appropriateness of Percutaneous Coronary Interventions in Washington State

Appropriateness of Percutaneous Coronary Interventions in Washington State Appropriateness of Percutaneous Coronary Interventions in Washington State Steven M. Bradley, Charles Maynard, Chris L. Bryson VA Puget Sound Healthcare System and University of Washington Presenter Disclosure

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018 Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018 No Disclosures The American Heart Association Evidence-Based Scoring

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center CMR Perfusion and Viability A STICH Out of Time? Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center Can Imaging Improve

More information

CLINICAL CONSEQUENCES OF THE

CLINICAL CONSEQUENCES OF THE CLINICAL CONSEQUENCES OF THE FAME STUDY TCT ASIA Seoul, Korea, april 26 th, 2012 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands GUIDELINES ESC SEPTEMBER 2010 FFR UPGRADED TO LEVEL

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

Modeling and Risk Prediction in the Current Era of Interventional Cardiology

Modeling and Risk Prediction in the Current Era of Interventional Cardiology Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.

More information

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan.

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan. Volume 1, Issue 1 Image Article Resolution of Inferior Wall Ischemia after Successful Revascularization of LAD Lesion: The Value of Myocardial Perfusion Imaging in Guiding Management of Multi-vessel CAD

More information

TRANSMYOCARDIAL REVASCULARIZATION

TRANSMYOCARDIAL REVASCULARIZATION TRANSMYOCARDIAL REVASCULARIZATION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices

More information

Δημήτριος Αγγοσράς, FETCS

Δημήτριος Αγγοσράς, FETCS ΣΕΜΙΝΑΡΙΟ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ Δημήτριος Αγγοσράς, FETCS Επίκοσρος Καθηγηηής Καρδιοτειροσργικής Ιαηρική Πανεπιζηημίοσ Αθηνών Πανεπιζηημιακό Γενικό Νοζοκομείο Αηηικόν Randomized Controlled Trials (RCTs) Why

More information

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

The PAIN Pathway for the Management of Acute Coronary Syndrome

The PAIN Pathway for the Management of Acute Coronary Syndrome 2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina

More information

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER ICPS, Massy ICV-GVM La Roseraie, Aubervilliers Hôpital FOCH, Suresnes Disclosure Statement of Financial

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Surgery Grand Rounds

Surgery Grand Rounds Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000

More information

03/07/ Background. + High Risk Features Are Prevalent in Dialysis Patients

03/07/ Background. + High Risk Features Are Prevalent in Dialysis Patients + When Does Cardiovascular Disease Preclude Consideration of Renal Transplantation? Kul Aggarwal, MD, MRCP (UK), FACC Professor of Clinical Medicine Division of Cardiology University of Missouri & Chief,

More information

Fractional Flow Reserve: Review of the latest data

Fractional Flow Reserve: Review of the latest data Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most

More information

Percutaneous coronary intervention of RIMA. The real challenge!

Percutaneous coronary intervention of RIMA. The real challenge! Percutaneous coronary intervention of RIMA The real challenge! Speaker's name: I do not have any potential conflict of interest Clinical Case 76-year old woman Previous History Actual Disease Diabetes

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

What the Cardiologist needs to know from Medical Images

What the Cardiologist needs to know from Medical Images What the Cardiologist needs to know from Medical Images Gerald Maurer Department of Cardiology Medical University of Vienna What kinds of Cardiologists Plumbers Electricians Photographers And then there

More information

Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention

Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention Appropriate Use Criteria Effective Date: March 9, 2019 Proprietary Date of Origin: 08/27/2015 Last revised: 02/01/2018 Last reviewed:

More information

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Volume 1, Issue 1 Case Report Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Robert F. Riley * and Bill Lombardi University of Washington Medical Center, Division

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Victor Cheng, M.D. Director, Cardiovascular CT Oklahoma Heart Institute 1 Disclosures Tornadoes scare me 2 Treating CAD Fixing

More information